Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1986 Mar 1;163(3):740-5.
doi: 10.1084/jem.163.3.740.

Modulation of endothelial cell hemostatic properties by tumor necrosis factor

Modulation of endothelial cell hemostatic properties by tumor necrosis factor

P P Nawroth et al. J Exp Med. .

Abstract

Tumor necrosis factor/cachectin (TNF) is a mediator of the septic state, which involves diffuse abnormalities of coagulation throughout the vasculature. Since previous studies have shown that endothelial cells can play an active role in coagulation, we wished to determine whether TNF could modulate endothelial cell hemostatic properties. Incubation of purified recombinant TNF with cultured endothelial cells resulted in a time- and dose-dependent acquisition of tissue factor procoagulant activity. Concomitant with enhanced procoagulant activity, TNF also suppressed endothelial cell cofactor activity for the anticoagulant protein C pathway; both thrombin-mediated protein C activation and formation of functional activated protein C-protein S complex on the cell surface were considerably attenuated. Comparable concentrations of TNF (half-maximal affect at approximately 50 pM) and incubation times (half-maximal affect by 4 h after addition to cultures) were required for each of these changes in endothelial cell coagulant properties. This unidirectional shift in cell surface hemostatic properties favoring promotion of clot formation indicates that, in addition to leukocyte procoagulants, endothelium can potentially be instrumental in the pathogenesis of the thrombotic state associated with inflammatory and malignant disorders.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Thromb Res. 1985 Dec 1;40(5):677-91 - PubMed
    1. J Clin Invest. 1981 Jun;67(6):1665-71 - PubMed
    1. J Biol Chem. 1981 Aug 25;256(16):8324-31 - PubMed
    1. J Clin Invest. 1984 Jul;74(1):1-6 - PubMed
    1. J Exp Med. 1984 Aug 1;160(2):618-23 - PubMed